文献速递神经儿科影像MR

基于多参数MRI的髓母细胞瘤分子亚群与预后机器学习系统

Multiparametric MRI-based machine learning system of molecular subgroups and prognosis in medulloblastoma.
PubMed 文献 · Eur Radiol · 2025-01-30

研究纳入北京天坛医院139例髓母细胞瘤患者,用新型多参数卷积神经网络Bi-ResNet-MB提取MRI特征进行分子亚群分类,平均AUC 0.946(95%CI 0.899-0.993),并在108例独立验证集中达0.894(95%CI 0.797-1.000)。基于XGBoost的预后模型预测1、3、5年OS的AUC分别为0.840、0.949、0.960,PFS的AUC分别为0.946、0.932、0.964,并据此提出基于M2R评分的风险分层系统。

要点

  • Bi-ResNet-MB模型在训练集分子亚群分类平均AUC 0.946,独立验证集平均AUC 0.894。
  • 预后模型训练集1、3、5年OS的AUC为0.840、0.949、0.960,PFS为0.946、0.932、0.964。
  • 独立验证集1、3、5年PFS预测AUC为0.832、0.875、0.907,提出基于M2R评分的风险分层系统。

核心结论

  • 基于机器学习和MRI数据的髓母细胞瘤分子亚群与预后预测模型及新型风险分层系统可能显著获益于患者。

研究设计与样本

  • 研究论文,训练集为北京天坛医院139例髓母细胞瘤患者(36例女性,平均年龄7.27±3.62岁),独立验证集108例(33例女性,平均年龄7.11±2.92岁),采用多参数卷积神经网络Bi-ResNet-MB提取MRI特征,并以XGBoost建立预后模型。

诊断标准与关键数值

  • Bi-ResNet-MB模型分子亚群分类训练集平均AUC 0.946(95%CI 0.899-0.993),独立验证集平均AUC 0.894(95%CI 0.797-1.000)。
  • 预后模型训练集OS的AUC在1、3、5年分别为0.840(95%CI 0.792-0.888)、0.949(95%CI 0.899-0.999)、0.960(95%CI 0.915-1.000)。
  • 预后模型训练集PFS的AUC在1、3、5年分别为0.946(95%CI 0.905-0.987)、0.932(95%CI 0.875-0.989)、0.964(95%CI 0.921-1.000)。
  • 独立验证集PFS预测AUC在1、3、5年分别为0.832(95%CI 0.724-0.920)、0.875(95%CI 0.781-0.967)、0.907(95%CI 0.760-1.000)。
  • 提出基于M2R评分(机器学习髓母细胞瘤风险评分)的风险分层系统。

临床应用与阅片要点

  • 作者认为,利用无创的术前诊断与评估有助于临床医生制定个体化治疗方案,尤其对高危患者,并为后续实施髓母细胞瘤新辅助治疗奠定基础。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: We aimed to use artificial intelligence to accurately identify molecular subgroups of medulloblastoma (MB), predict clinical outcomes, and incorporate deep learning-based imaging features into the risk stratification.

METHODS: The MRI features were extracted for molecular subgroups by a novel multi-parameter convolutional neural network (CNN) called Bi-ResNet-MB. Then, MR features were used to establish a prognosis model based on XGBoost. Finally, a novel risk stratification system to stratify the patients based on the M2R Score (Machine learning-based Medulloblastoma Risk Score) was proposed.

RESULTS: A total of 139 MB patients (36 female, average age 7.27 ± 3.62 years) were treated at Beijing Tiantan Hospital. The Bi-ResNet-MB model excelled in molecular subgroup classification, achieving an average AUC of 0.946 (95% CI: 0.899-0.993). For prognostic prediction, our models achieved AUCs of 0.840 (95% CI: 0.792-0.888), 0.949 (95% CI: 0.899-0.999), and 0.960 (95% CI: 0.915-1.000) for OS, and 0.946 (95% CI: 0.905-0.987), 0.932 (95% CI: 0.875-0.989), and 0.964 (95% CI: 0.921-1.000) for PFS at 1, 3, and 5 years. In an independent validation dataset of 108 patients (33 female, average age 7.11 ± 2.92 years), the average AUC of molecular subgroup classification reached 0.894 (95% CI: 0.797-1.000). For PFS prediction at 1, 3, and 5 years, the AUCs were 0.832 (95% CI: 0.724-0.920), 0.875 (95% CI: 0.781-0.967), and 0.907 (95% CI: 0.760-1.000), respectively.

CONCLUSIONS: Based on machine learning and MRI data, models for MB molecular subgroups and prognosis prediction and the novel risk stratification system may significantly benefit patients.

KEY POINTS: Question Medulloblastoma exhibits significant heterogeneity, leading to considerable variations in patient prognosis and there is a lack of effective risk assessment strategies. Findings We have constructed a comprehensive machine learning system that excels in subgrouping diagnosis, prognosis assessment, and risk stratification for medulloblastoma patients preoperatively. Clinical relevance The utilization of non-invasive preoperative diagnosis and assessment is advantageous for clinicians in creating personalized treatment plans, particularly for high-risk patients. Additionally, it lays a foundation for the subsequent implementation of neoadjuvant therapy for medulloblastoma.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Liu Z, Ren S, Zhang H, et al. Multiparametric MRI-based machine learning system of molecular subgroups and prognosis in medulloblastoma. Eur Radiol. 2025. PMID: 39883158. doi:10.1007/s00330-025-11385-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。